City

Houston (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

lenalidomide (1)

obinutuzumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

bulky disease

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1

Active, not recruiting

Ann Arbor Stage II Grade 1 Follicular Lymphoma
+12 more

Lenalidomide
Obinutuzumab

Houston, Texas

M D Anderson Cancer Center

Feb 18, 2022